The Research Development Of Bromocriptine In The Treatment Of Prolactinomas

prolactinomas is one of the most common pituitary secretion adenomas,accounting for 40%～60%,female incidence was significantly higher than men,perhaps for the 10:1.In addition to pituitary prolactinoma can cause sight,vision barriers,can also cause hyperprolactinemia,resulting in reproductive age woman in galactorrhea,amenorrhea and infe- rtility,and male sexualdys function. Reported in the literature at home and abroad will bromocriptine treatment of pituitary micprolactinomas as the first choice. In the treatment of invasive giant prolactinomas in combined therapy of choice for bromocriptine,can effectively reduce blood PRL levels,improving the clinical symptoms.However , bromocriptine treatment of prolactinomasdosage,medication time,medication after the menstrual recovery rate,pregnancy rate,as well asdrng useduring pregnancy on the fetal effects of its side effects and treatment resistance,etc. have not made adetailed report,the situation will now be summarized as follow,for clinical reference.